These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2118 related items for PubMed ID: 34416901

  • 21. FOXP4-AS1 promotes CD8+ T cell exhaustion and esophageal cancer immune escape through USP10-stabilized PD-L1.
    Shen GY, Zhang Y, Huang RZ, Huang ZY, Yang LY, Chen DZ, Yang SB.
    Immunol Res; 2024 Aug; 72(4):766-775. PubMed ID: 38687433
    [Abstract] [Full Text] [Related]

  • 22. PLA2G2D promotes immune escape in non-small cell lung cancer by regulating T cell immune function through PD-L1-expressing extracellular vesicles.
    Jing H, Cao X, Li K, Liu Y, Meng M, Liu S, Ye M, Zhang J, Wu Y.
    Scand J Immunol; 2024 Sep; 100(3):e13393. PubMed ID: 38922971
    [Abstract] [Full Text] [Related]

  • 23. Circ-HSP90A expedites cell growth, stemness, and immune evasion in non-small cell lung cancer by regulating STAT3 signaling and PD-1/PD-L1 checkpoint.
    Lei J, Zhu J, Hui B, Jia C, Yan X, Jiang T, Wang X.
    Cancer Immunol Immunother; 2023 Jan; 72(1):101-124. PubMed ID: 35750765
    [Abstract] [Full Text] [Related]

  • 24. Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy.
    Zhang P, Ma Y, Lv C, Huang M, Li M, Dong B, Liu X, An G, Zhang W, Zhang J, Zhang L, Zhang S, Yang Y.
    Cancer Sci; 2016 Nov; 107(11):1563-1571. PubMed ID: 27581532
    [Abstract] [Full Text] [Related]

  • 25. ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers.
    Yu ZZ, Liu YY, Zhu W, Xiao D, Huang W, Lu SS, Yi H, Zeng T, Feng XP, Yuan L, Qiu JY, Wu D, Wen Q, Zhou JH, Zhuang W, Xiao ZQ.
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 37001908
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Circ_0072088 promotes the development of non-small cell lung cancer via the miR-377-5p/NOVA2 axis.
    Tan Z, Cao F, Jia B, Xia L.
    Thorac Cancer; 2020 Aug; 11(8):2224-2236. PubMed ID: 32524752
    [Abstract] [Full Text] [Related]

  • 28. CircDENND2D Inhibits PD-L1-Mediated Non-Small Cell Lung Cancer Metastasis and Immune Escape by Regulating miR-130b-3p/STK11 Axis.
    Chen Y, Chen X, Li Z, Zhu Y, Liu F, Cai J.
    Biochem Genet; 2023 Dec; 61(6):2691-2709. PubMed ID: 37222962
    [Abstract] [Full Text] [Related]

  • 29. Programmed cell death ligand-1 (PD-L1) expression combined with CD8 tumor infiltrating lymphocytes density in non-small cell lung cancer patients.
    El-Guindy DM, Helal DS, Sabry NM, Abo El-Nasr M.
    J Egypt Natl Canc Inst; 2018 Dec; 30(4):125-131. PubMed ID: 30337185
    [Abstract] [Full Text] [Related]

  • 30. A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy.
    Wang Y, Gu T, Tian X, Li W, Zhao R, Yang W, Gao Q, Li T, Shim JH, Zhang C, Liu K, Lee MH.
    Front Immunol; 2021 Dec; 12():654463. PubMed ID: 34054817
    [Abstract] [Full Text] [Related]

  • 31. Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
    Jin R, Liu C, Zheng S, Wang X, Feng X, Li H, Sun N, He J.
    Cancer Biol Med; 2020 Aug 15; 17(3):768-781. PubMed ID: 32944405
    [Abstract] [Full Text] [Related]

  • 32. Circular RNA SMARCA5 suppressed non-small cell lung cancer progression by regulating miR-670-5p/RBM24 axis.
    Zhang D, Ma Y, Ma Z, Liu S, Sun L, Li J, Zhao F, Li Y, Zhang J, Li S, Jiang J.
    Acta Biochim Biophys Sin (Shanghai); 2020 Oct 19; 52(10):1071-1080. PubMed ID: 33085761
    [Abstract] [Full Text] [Related]

  • 33. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer.
    Wan W, Ao X, Chen Q, Yu Y, Ao L, Xing W, Guo W, Wu X, Pu C, Hu X, Li Z, Yao M, Luo D, Xu X.
    Mol Cancer; 2022 Feb 23; 21(1):60. PubMed ID: 35197058
    [Abstract] [Full Text] [Related]

  • 34. Hsa_circ_0004872 mitigates proliferation, metastasis and immune escape of meningioma cells by suppressing PD-L1.
    Chen K, Huang Z, Liu C, Ouyang Q, Yan Q, Zheng W, Huang Y.
    Metab Brain Dis; 2024 Jun 23; 39(5):895-907. PubMed ID: 38771413
    [Abstract] [Full Text] [Related]

  • 35. N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1.
    Li J, Xu X, Xu K, Zhou X, Wu K, Yao Y, Liu Z, Chen C, Wang L, Sun Z, Jiao D, Han X.
    J Exp Clin Cancer Res; 2024 Apr 20; 43(1):119. PubMed ID: 38641828
    [Abstract] [Full Text] [Related]

  • 36. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
    Wang QM, Lian GY, Song Y, Huang YF, Gong Y.
    Life Sci; 2019 Aug 15; 231():116335. PubMed ID: 30898647
    [Abstract] [Full Text] [Related]

  • 37. Endoplasmic reticulum stress-induced exosomal miR-27a-3p promotes immune escape in breast cancer via regulating PD-L1 expression in macrophages.
    Yao X, Tu Y, Xu Y, Guo Y, Yao F, Zhang X.
    J Cell Mol Med; 2020 Sep 15; 24(17):9560-9573. PubMed ID: 32672418
    [Abstract] [Full Text] [Related]

  • 38. CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis.
    Gao C, Xu YJ, Qi L, Bao YF, Zhang L, Zheng L.
    Cell Biol Toxicol; 2022 Oct 15; 38(5):825-845. PubMed ID: 34018092
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1.
    Kuang Z, Liu X, Zhang N, Dong J, Sun C, Yin M, Wang Y, Liu L, Xiao D, Zhou X, Feng Y, Song D, Deng H.
    Cell Death Differ; 2023 Oct 15; 30(10):2249-2264. PubMed ID: 37670038
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 106.